NASDAQ · DCBO
Docebo financials
$22.78−0.26%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $242.7M | $216.9M | $180.8M | $142.9M | $104.2M | $62.9M |
| Gross profit | $194.8M | $175.6M | $146.3M | $114.7M | $83.5M | $51.4M |
| Gross margin | 80.3% | 81.0% | 80.9% | 80.3% | 80.1% | 81.7% |
| Operating income | $24.5M | $18.9M | $680.0K | -$6.9M | -$13.0M | -$5.9M |
| Net income | $37.5M | $26.7M | $2.8M | $7.0M | -$13.6M | -$8.0M |
| Net margin | 15.5% | 12.3% | 1.6% | 4.9% | −13.0% | −12.7% |
| Diluted EPS | $1.28 | $0.86 | $0.08 | $0.21 | $-0.41 | $-0.28 |
| EBITDA | $27.7M | $22.3M | $3.8M | -$4.6M | -$11.0M | -$4.6M |
| Operating cash flow | $28.2M | $29.2M | $16.0M | $2.3M | -$3.3M | $4.8M |
| Free cash flow | $27.2M | $28.0M | $15.3M | $1.2M | -$4.4M | $3.7M |
| Diluted shares | 29.4M | 31.0M | 33.7M | 34.0M | 32.9M | 28.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.0M | $92.5M | $72.0M | $216.3M | $215.3M | $219.7M |
| Short-term investments | $0.00 | $0.00 | $83.0K | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $4.0M | $3.8M |
| Total assets | $206.6M | $190.7M | $158.4M | $283.7M | $268.2M | $254.2M |
| Total liabilities | $132.6M | $133.0M | $107.7M | $91.5M | $77.6M | $53.9M |
| Shareholders' equity | $74.1M | $57.8M | $50.7M | $192.2M | $190.7M | $200.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology